Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRUSADERS: Reduced Sodium Chloride in Fluid Creep and Maintenance Fluids in Critically Ill Adults
NCT07189091Phase 4Recruiting
- Start
- Oct 2025
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium potassium magnesium calcium and glucose injection, dextrose + sodium chloride in critical illness, Fluid and electrolyte imbalance. Started Oct 2025; status: recruiting.
02
Drugs
sodium potassium magnesium calcium and glucose injectiondextrose + sodium chloride
03
Conditions
critical illnessFluid and electrolyte imbalance
Beyond the preview
Go deeper on NCT07189091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07189091.